Brought to you by Freeths, Discovery Park and ICR Healthcare, this clinical trials panel discussion brings together life sciences companies that have reached, or are actively entering, the clinical trials phase - sharing practical insight into the decisions, challenges and opportunities that define this pivotal stage of growth.
This event will focus on real world experiences of delivering clinical trials, including why particular regions were selected, how those decisions have played out in practice, and what organisations would do differently with the benefit of hindsight.
The discussion will also explore what the UK can do to strengthen its competitiveness as a destination for clinical trials, from infrastructure and regulation through to policy and support for scaling businesses.
The panel discussion will be led by companies currently operating in this space, including:
- Heather Ramsay, Strategic Development & Enterprise Lead, NIHR BioResource
- Nara Daubeney, Co Founder and Chief Executive Officer, Phaim
- Rosie Rodriguez, President, Growth at Relation Therapeutics
- Sam Kamali, Chief Executive Officer, MyoNerv
Our sessions are hosted by seasoned growth leaders and practitioners who are deep in the work right now. And are designed to foster open, candid discussion rather than formal presentations, enabling participants to share practical insights, discuss challenges openly and learn from peers facing similar decisions.
The discussion will be interactive, with opportunities to ask questions, share perspectives and engage directly with speakers. Attendees should expect to leave with practical insights and informed perspectives that can be applied within their own organisations.
We hope you will be able to join us for what promises to be a thoughtful, constructive and highly relevant conversation.
